Concentra Group Holdings Parent, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CON research report →
Range $30 – $50
Price Chart
About the company
Concentra Group Holdings Parent, Inc. is a U. S.
- CEO
- Matthew T. DiCanio
- IPO
- 2024
- Employees
- 9,983
- HQ
- Addison, TX, US
Get TickerSpark's AI analysis on CON
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $5.29B
- P/E
- 24.53
- Fwd P/E
- 24.16
- PEG
- 0.62
- P/S
- 2.24
- P/B
- 10.39
- EV/EBITDA
- 15.23
- Div Yield
- 0.60%
- Gross Margin
- 29.90%
- Op Margin
- 16.93%
- Net Margin
- 9.26%
- ROE
- 48.02%
- ROIC
- 10.99%
Latest fiscal year · YoY change
- Revenue
- $2.16B+13.9%
- Gross Profit
- $613.09M+16.1%
- Op Income
- $333.99M
- Net Income
- $166.41M-0.1%
- EPS
- $1.39+6.9%
- OCF Growth
- +1.7%
- FCF Growth
- -6.3%
- 52W High
- $44.22
- 52W Low
- $19.05
- 50D MA
- $38.52
- 200D MA
- $29.92
- Beta
- 0.63
- RSI (14)
- 54
- Avg Volume
- 1.05M
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Concentra posted another strong quarter with higher visits, better pricing, and disciplined costs driving double-digit earnings growth, and it raised full-year 2026 guidance.· November 6, 2026
- Revenue rose 8.6% year over year to $622.1 million; adjusted EPS was $0.52, up 33.3%, and adjusted EBITDA increased 17.9% to $140.2 million.
- Occupational health center visits increased 4.9%, with workers' comp visits up 4.2% and employer services visits up 5.8%.
- Revenue per visit increased 3.3%, supported by 3.5% workers' comp rate growth and 4.0% employer services rate growth.
- Adjusted EBITDA margin expanded 178 basis points to 22.5%; management cited strong flow-through and operating efficiencies.
- Management raised 2026 revenue and adjusted EBITDA guidance and said it expects employer services pricing to stay around its long-term 3% rate trend.
Total revenue was $622.1 million in Q3 2026 versus $572.8 million a year ago, up 8.6%. Net income attributable to the company was $65.9 million, or $0.52 per share, versus $48.3 million, or $0.38 per share, in Q3 2025. Adjusted net income was $66.1 million and adjusted EPS was $0.52 versus $49.9 million and $0.39 a year ago. Adjusted EBITDA was $140.2 million, up 17.9%, and adjusted EBITDA margin expanded 178 basis points to 22.5%. Total occupational health center revenue was $569.7 million, workers' compensation revenue $370.5 million, employer services revenue $190.5 million, on-site revenue $38.4 million, and other businesses revenue $14.1 million. Operating cash flow was $51.9 million, free cash flow was $32.2 million, cash balance was $85.8 million, total debt was $1.52 billion, and net leverage was 2.9x. The company raised 2026 revenue guidance to $2.36 billion to $2.38 billion and adjusted EBITDA guidance to $505 million to $510 million; free cash flow guidance of $220 million to $240 million and capex guidance of $70 million to $80 million were unchanged.
Matthew DiCanio said the quarter reflected strong visit volume, higher revenue per visit, and disciplined cost management, and he framed the company as benefiting from favorable labor market conditions plus market share gains. He emphasized broad-based growth across regions and end markets, strong customer retention, and continued investment in sales execution, account management, and technology. He also highlighted the completion of separation activities, continued M&A and de novo opportunities, and a confident but measured tone on sustaining growth.
Tanner Newton walked through the financials, pointing to $622.1 million of revenue, $140.2 million of adjusted EBITDA, and 22.5% adjusted EBITDA margin, with margin helped by volume, rate growth, and operating efficiencies. He noted cost of services improved to 68.6% of revenue from 70.8% a year ago, while adjusted G&A was 9.1% of revenue versus 8.5% last year, partly due to some one-time items. On cash and capital allocation, he said operating cash flow was $51.9 million, free cash flow was $32.2 million, the company repurchased 1 million shares for $34.65 million, paid $8 million in dividends, repaid $52.4 million of Term Loan B, ended with $85.8 million of cash and $1.52 billion of debt, and launched a new $250 million share repurchase authorization.
Analysts focused on whether recent volume strength was more about market share gains, industry conditions, or a sustainable shift in demand. Management said the growth was broad-based, retention is near all-time highs, and market share gains are helping, but they also stressed they need more than one quarter to confirm trends like the pickup in employer services as a leading indicator for workers' comp. Questions also covered New York pricing, 2027 fee schedules, and de novo ramp-up; management said New York is still under review, fee schedule visibility should improve over the next 30 to 60 days, and de novos are being supported by early sales outreach, open houses, and strong local ramp processes.
The bull case from this call is that Concentra is still seeing strong, broad-based demand, with visits, pricing, and margins all moving higher at the same time. Management sounded confident that retention, new business wins, technology investments, and a healthy pipeline of de novos and bolt-on M&A can support continued growth, while leverage has come down to 2.9x and buybacks give added capital allocation flexibility.
The main caution is that some of the strongest demand signals may be cyclical or still too early to call durable, especially the recent lift in employer services volume that management said needs more than one quarter to validate. Management also flagged uncertainty around 2027 fee schedules, the timing of New York implementation, and the fact that 2026 margin expansion may not repeat at the same pace next year once separation-related benefits normalize.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 90.4%
- Shares Outstanding
- 126.52M
- Float Shares
- 114.38M
of shares held by institutions
295 13F filers
Buy/sell ratio 0.79. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Congressional trading
Senate and House stock disclosures for CON, newest first.
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Blackrock, Inc. | 18.16M | ▲ 402.65K |
| Price T Rowe Associates Inc | 14.81M | ▼ 2.90M |
| Vanguard Group Inc | 12.60M | ▼ 601.30K |
| Vanguard Portfolio Management LLC | 7.06M | ▲ 237.81K |
| Vanguard Capital Management LLC | 5.31M | ▲ 183.60K |
| State Street Corp | 4.82M | ▼ 15.96K |
| Invesco Ltd. | 3.97M | ▲ 1.04M |
| Geode Capital Management, LLC | 3.40M | ▲ 295.88K |
| Dimensional Fund Advisors LP | 3.24M | ▲ 11.92K |
| Barrow Hanley Mewhinney & Strauss LLC | 2.57M | ▼ 128.73K |
| Jpmorgan Chase & Co | 2.56M | ▼ 215.62K |
| Neuberger Berman Group LLC | 2.46M | ▲ 1.53M |
Held by 354 ETFs
Biggest fund positions in CON by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Nov 17, 26 | deLorimier John A. | sell | 17,444 |
| Nov 17, 26 | Newton Raymond Tanner | sell | 2,843 |
| Nov 16, 26 | Newton William Keith | sell | 68,232 |
| Nov 16, 26 | Devasia Thomas A. | sell | 18,194 |
| Nov 6, 26 | ORTENZIO ROBERT A | sell | 250,000 |
| Nov 6, 26 | ORTENZIO ROBERT A | sell | 150,000 |
| Nov 6, 26 | ORTENZIO ROBERT A | sell | 305,000 |
| Nov 6, 26 | ORTENZIO ROBERT A | sell | 25,000 |
| Nov 6, 26 | ORTENZIO ROBERT A | sell | 35,000 |
| Nov 4, 26 | Anderson John Robert Jr. | other | 13,080 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our CON coverage
Recent articles, reports, and earnings notes.
No research on CON yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CON report →CON or MEDP: Which Is the Better Value Stock Right Now?
zacks.com · Nov 18
Concentra Group (CON) Is Up 4.56% in One Week: What You Should Know
zacks.com · Nov 10
Take the Zacks Approach to Beat the Markets: Ulta Beauty, Accenture, HCA in Focus
zacks.com · Nov 9
Concentra Group Holdings Parent Q3 Earnings Call Highlights
marketbeat.com · Nov 6
Concentra Group Holdings Parent, Inc. (CON) Q3 2026 Earnings Call Transcript
seekingalpha.com · Nov 6
Concentra Group (CON) Tops Q3 Earnings and Revenue Estimates
zacks.com · Nov 5
CON EDISON REPORTS 2026 THIRD QUARTER EARNINGS
prnewswire.com · Nov 5
Concentra Announces Results For Its Third Quarter Ended September 30, 2026 and Raises FY 2026 Guidance
businesswire.com · Nov 5
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.